Marco Cordani

Universidad Complutense de Madrid — Spain

Medicine · Health Sciences

31h-index4.6kcitations99works10.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Autophagy in Disease and Therapy(38), Cancer, Hypoxia, and Metabolism(17), Cancer-related Molecular Pathways(16), Epigenetics and DNA Methylation(9), MicroRNA in disease regulation(8)

Publications99 total

The Role of Glycolysis in Tumorigenesis—The Many Unresolved Issues
Preprints.org·2026Open Access
Autophagy and cellular metabolism in civilization diseases
European Journal of Pharmacology·2026
Unraveling stress-adaptation pathways in cancer: Functional dissection through CRISPR-based genetic screens
Cancer Letters·2026
Targeting the CCL2/CCR2 axis in colorectal cancer: Immunopharmacological perspectives and therapeutic strategies
Critical Reviews in Oncology/Hematology·2025
Shifting tides from non-targeted chemotherapy to targeted therapies and small RNA-based bio drugs: A changing paradigm in cancer therapy
European Journal of Pharmacology·2025
Comprehensive pan-cancer analysis of p62 reveals its contribution to shaping tumor microenvironment and anti-tumor immunity
Discover Oncology·2025Open Access
Mechanisms and etiology of male health disorders: hormones, cancer, and fertility
Cell Communication and Signaling·2025Open Access
Biomedical advances and clinical challenges of graphitic carbon nitride quantum dots: A comprehensive review
Inorganic Chemistry Communications·2025· 1 cited
Oxidative and Glycolytic Metabolism: Their Reciprocal Regulation and Dysregulation in Cancer
Cells·2025· 8 citedOpen Access
CSNK2A1 confers gemcitabine resistance to pancreatic ductal adenocarcinoma via inducing autophagy
Cancer Letters·2025
Advances in nanoparticle-mediated transdermal delivery of nucleic acids as therapy of skin disorders and cancer
Current Opinion in Biomedical Engineering·2025· 1 citedOpen Access
Mechanistic insights and therapeutic strategies for targeting autophagy in pancreatic ductal adenocarcinoma
Discover Oncology·2025· 4 citedOpen Access
A non‐fluorescent immunohistochemistry method for measuring autophagy flux using <scp>MAP1LC3</scp>/<scp>LC3</scp> and <scp>SQSTM1</scp> as core markers
FEBS Open Bio·2025· 1 citedOpen Access
Drug repositioning and experimental validation for targeting ZZ domain of p62 as a cancer treatment
Computers in Biology and Medicine·2025· 2 cited
Non-coding RNAs as mediators of epithelial to mesenchymal transition in metastatic colorectal cancers
Cellular Signalling·2025· 1 citedOpen Access
Carbon-based nanozymes for cancer therapy and diagnosis: A review
International Journal of Biological Macromolecules·2025· 20 cited
Small-molecule inhibitors of WNT signalling in cancer therapy and their links to autophagy and apoptosis
European Journal of Pharmacology·2024· 6 cited
Highlighting roles of autophagy in human diseases: a perspective from single-cell RNA sequencing analyses
Drug Discovery Today·2024· 4 citedOpen Access
The role of glycolysis in tumorigenesis: From biological aspects to therapeutic opportunities
Neoplasia·2024· 25 citedOpen Access
Drug repositioning identifies potential autophagy inhibitors for the LIR motif p62/SQSTM1 protein
Computational Biology and Chemistry·2024· 8 cited
page 1 of 5Next →

Frequent Co-authors

Massimo Donadelli(19), Raffaele Strippoli(11), Ali Zarrabi(10), Ilaria Dando(9), Álvaro Somoza(7), Raffaella Pacchiana(7), Giovanna Butera(6), Elisa Dalla Pozza(5), Marta Palmieri(5), Saeid Ghavami(5), Miguel Sánchez‐Álvarez(5), Jordi Oliver(4), Pilar Roca(4), Elena Butturini(3), Flavia Trionfetti(3), Margalida Torrens‐Mas(3), Alexandr V. Bazhin(3), Atefeh Zarepour(3), Mehrdad Aghaei(3), Vahid Erfani‐Moghadam(3)